Klaviyo Q3 revenue up 32%, beats estimates

Reuters
11/06
Klaviyo Q3 revenue up 32%, beats estimates

Overview

  • Klaviyo Q3 revenue grows 32% yr/yr to $310.9 mln, beating analyst expectations

  • Company raises FY25 revenue guidance to $1.215 bln-$1.219 bln, indicating 30% growth

  • Klaviyo reports net loss for Q3 despite strong revenue growth

Outlook

  • Klaviyo raises FY25 revenue guidance to $1.215 bln to $1.219 bln

  • Company expects Q4 revenue between $331 mln and $335 mln

  • Company projects Q4 non-GAAP operating margin of 13% to 14%

Result Drivers

  • LARGE CUSTOMER GROWTH - Klaviyo saw a 36% increase in customers generating over $50,000 in ARR, indicating strong growth among larger clients

  • INTERNATIONAL EXPANSION - Revenue in EMEA and APAC grew 43% year-over-year, driven by international expansion

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$310.90 mln

$299.86 mln (21 Analysts)

Q3 Net Income

-$426,000

Q3 Adjusted Gross Profit

$237.10 mln

Q3 Adjusted Operating Profit

$45 mln

Q3 Gross Profit

$234.70 mln

Q3 Pretax Profit

-$614,000

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the software peer group is "buy"

  • Wall Street's median 12-month price target for Klaviyo Inc is $45.00, about 42.2% above its November 4 closing price of $26.00

  • The stock recently traded at 37 times the next 12-month earnings vs. a P/E of 48 three months ago

Press Release: ID:nBw7cRFjca

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10